TipRanks
CellaVision AB (GB:0MR5)
LSE:0MR5
UK Market

CellaVision AB (0MR5) Ratios

0 Followers

CellaVision AB Ratios

GB:0MR5's free cash flow for Q3 2026 was kr0.66. For the 2026 fiscal year, GB:0MR5's free cash flow was decreased by kr and operating cash flow was kr0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.48 3.98 3.72 3.07 2.83
Quick Ratio
2.62 2.97 2.56 2.01 1.76
Cash Ratio
1.60 1.70 1.38 1.02 0.81
Solvency Ratio
0.66 0.89 0.89 0.80 0.63
Operating Cash Flow Ratio
1.54 1.81 1.84 1.65 1.03
Short-Term Operating Cash Flow Coverage
12.81 14.66 14.00 5.45 3.26
Net Current Asset Value
kr 217.15Mkr 233.78Mkr 205.49Mkr 153.27Mkr 127.02M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.02 0.03 0.07 0.11
Debt-to-Equity Ratio
0.05 0.03 0.03 0.09 0.16
Debt-to-Capital Ratio
0.05 0.03 0.03 0.08 0.14
Long-Term Debt-to-Capital Ratio
0.03 0.01 <0.01 0.04 0.09
Financial Leverage Ratio
1.28 1.23 1.24 1.30 1.39
Debt Service Coverage Ratio
9.14 8.04 8.22 4.41 3.78
Interest Coverage Ratio
73.32 18.86 21.78 51.24 67.64
Debt to Market Cap
0.01 <0.01 <0.01 0.01 0.02
Interest Debt Per Share
2.19 1.52 1.47 2.85 4.40
Net Debt to EBITDA
-0.81 -0.69 -0.56 -0.27 -0.03
Profitability Margins
Gross Profit Margin
68.01%68.50%67.35%68.37%68.56%
EBIT Margin
23.12%27.01%25.58%24.73%24.75%
EBITDA Margin
27.47%31.26%30.39%30.60%31.03%
Operating Profit Margin
22.97%26.62%24.57%24.66%24.75%
Pretax Profit Margin
22.93%25.60%24.45%24.25%23.22%
Net Profit Margin
18.08%20.17%19.46%19.24%18.51%
Continuous Operations Profit Margin
18.08%20.17%19.46%19.24%18.51%
Net Income Per EBT
78.83%78.80%79.57%79.35%79.72%
EBT Per EBIT
99.84%96.14%99.54%98.31%93.78%
Return on Assets (ROA)
11.57%13.98%13.91%14.03%13.27%
Return on Equity (ROE)
15.24%17.25%17.25%18.19%18.44%
Return on Capital Employed (ROCE)
16.60%20.54%19.66%20.63%20.86%
Return on Invested Capital (ROIC)
12.88%15.96%15.40%15.68%15.76%
Return on Tangible Assets
21.91%27.05%26.84%26.30%24.03%
Earnings Yield
2.96%4.08%2.71%2.58%2.17%
Efficiency Ratios
Receivables Turnover
5.48 5.38 5.77 6.93 5.35
Payables Turnover
6.17 6.69 7.33 6.59 4.20
Inventory Turnover
2.06 2.14 1.89 1.70 1.41
Fixed Asset Turnover
5.06 6.20 6.03 5.40 5.81
Asset Turnover
0.64 0.69 0.71 0.73 0.72
Working Capital Turnover Ratio
2.37 2.43 2.68 2.76 2.70
Cash Conversion Cycle
184.50 183.98 206.36 212.00 240.13
Days of Sales Outstanding
66.62 67.84 63.23 52.70 68.17
Days of Inventory Outstanding
177.04 170.69 192.94 214.72 258.87
Days of Payables Outstanding
59.15 54.55 49.80 55.43 86.91
Operating Cycle
243.66 238.53 256.16 267.42 327.04
Cash Flow Ratios
Operating Cash Flow Per Share
8.85 8.41 8.32 8.24 5.76
Free Cash Flow Per Share
6.50 7.62 5.06 4.61 2.84
CapEx Per Share
2.35 0.79 3.26 3.63 2.91
Free Cash Flow to Operating Cash Flow
0.73 0.91 0.61 0.56 0.49
Dividend Paid and CapEx Coverage Ratio
1.73 2.56 1.51 1.40 1.17
Capital Expenditure Coverage Ratio
3.76 10.66 2.55 2.27 1.98
Operating Cash Flow Coverage Ratio
4.24 7.82 7.39 3.04 1.34
Operating Cash Flow to Sales Ratio
0.28 0.26 0.27 0.29 0.21
Free Cash Flow Yield
3.32%4.85%2.33%2.17%1.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
33.84 24.49 36.86 38.80 46.16
Price-to-Sales (P/S) Ratio
6.11 4.94 7.17 7.47 8.54
Price-to-Book (P/B) Ratio
5.00 4.22 6.36 7.06 8.51
Price-to-Free Cash Flow (P/FCF) Ratio
30.10 20.63 42.98 45.99 80.50
Price-to-Operating Cash Flow Ratio
22.10 18.70 26.14 25.74 39.79
Price-to-Earnings Growth (PEG) Ratio
-3.77 2.78 4.57 3.85 -8.36
Enterprise Value Multiple
21.46 15.12 23.05 24.12 27.51
Enterprise Value
4.50B 3.59B 5.07B 5.00B 5.46B
EV to EBITDA
21.46 15.12 23.05 24.12 27.51
EV to Sales
5.89 4.73 7.00 7.38 8.53
EV to Free Cash Flow
29.02 19.74 41.97 45.47 80.42
EV to Operating Cash Flow
21.30 17.89 25.53 25.45 39.75
Tangible Book Value Per Share
15.54 15.04 13.76 11.87 10.16
Shareholders’ Equity Per Share
39.13 37.21 34.20 30.03 26.90
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.20 0.21 0.20
Revenue Per Share
31.99 31.82 30.32 28.40 26.80
Net Income Per Share
5.78 6.42 5.90 5.46 4.96
Tax Burden
0.79 0.79 0.80 0.79 0.80
Interest Burden
0.99 0.95 0.96 0.98 0.94
Research & Development to Revenue
0.14 0.13 0.12 0.12 0.14
SG&A to Revenue
0.31 0.29 0.31 0.11 0.12
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.37 1.31 1.41 1.51 0.92
Currency in SEK